Global Next-Generation Sequencing Informatics Market Projected to Expand at 16.7% CAGR by 2029
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Next-Generation Sequencing Informatics Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The next-generation sequencing informatics market has experienced substantial growth in recent years. It is projected to expand from $8.73 billion in 2024 to $10.23 billion by 2025, achieving a compound annual growth rate (CAGR) of 17.1%. This historical expansion can be attributed to several factors, including the increasing adoption of personalized medicine, the rising applications of next-generation sequencing (NGS) in disease diagnosis, a growing demand for biomarker discovery, a heightened focus on genomic research, and the increasing integration of artificial intelligence (AI) within sequencing informatics.
The next-generation sequencing informatics market is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $19.00 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 16.7%. Key factors contributing to this growth during the forecast period include the expanding application of sequencing informatics in clinical diagnostics, the growing adoption of artificial intelligence (AI) in drug discovery processes, heightened demand for multi-omics data analysis, increased uptake of cloud-based next-generation sequencing (NGS) analytics, and a greater focus on precision medicine. Significant trends expected within the forecast period encompass progress in cloud-based next-generation sequencing (NGS) solutions, enhancements in data analysis tools specifically for next-generation sequencing (NGS) informatics, the incorporation of artificial intelligence (AI) and machine learning (ML) into genomic data interpretation, the creation of improved visualization and workflow management systems, and ongoing advancements in personalized medicine.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28282&type=smp
What Are The Top Growth Drivers Impacting The Next-Generation Sequencing Informatics Market Outlook?
The expanding embrace of personalized medicine is anticipated to fuel the expansion of the next-generation sequencing informatics market in the foreseeable future. Personalized medicine describes a healthcare strategy that customizes treatment and prevention plans based on an individual’s distinct genetic composition, way of life, and surroundings. The growing acceptance of personalized medicine stems largely from breakthroughs in genomics, allowing for the accurate detection of genetic differences and customized therapies. Next-generation sequencing informatics bolsters personalized medicine through its offering of thorough genomic data analysis, rendering it perfectly suited for bespoke treatment approaches and precision healthcare. It lessens diagnostic ambiguity by pinpointing genetic variations and forecasting disease susceptibility, thereby enhancing clinical judgment and patient results. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, marking a considerable rise from the 12 approved in 2022. Consequently, the rising adoption of personalized medicine is propelling the development of the next-generation sequencing informatics market.
What Are The Major Segment Types Covered In The Next-Generation Sequencing Informatics Market?
The next-generation sequencing informatics market covered in this report is segmented as
1) By Offering: Software, Platforms, Services
2) By Product And Services: Storage And Computing Tools, Commercial Data Analysis, Data Interpretation And Reporting Tools, Informatics Services, Laboratory Information Management Systems (LIMS)
3) By Deployment Mode: Cloud, On-Premise, Hybrid
4) By Application: Research And Development, Clinical Diagnostics, Drug Discovery, Agrigenomics
5) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinical Laboratories, Agricultural Biotechnology Companies
Subsegments:
1) By Software: Data Analysis Software, Data Management And Storage Tools, Workflow Management Software, Sequence Alignment Tools, Variant Analysis Software, Clinical Interpretation Software
2) By Platforms: On-Premises Platforms, Cloud-Based Platforms, Hybrid Platforms
3) By Services: Data Analysis Services, Consulting And Implementation Services, Data Management And Storage Services, Technical Support And Maintenance Services, Training And Education Services
What Trends Are Redefining The Next-Generation Sequencing Informatics Market Dynamics?
Leading companies in the next-generation sequencing informatics (NGS) market are concentrating on developing advanced solutions, such as cloud-based platforms, to enhance scalability, improve data security, and optimize genomic workflows. Cloud-based platforms are defined as digital infrastructures that enable researchers and clinicians to store, process, and analyze large volumes of sequencing data either using remote servers or within local institutional settings. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, unveiled Connected Insights, a new cloud-based software specifically designed for the tertiary analysis of clinical next-generation sequencing (NGS) data. This platform streamlines genomic data interpretation and reporting, integrates over 45 third-party knowledge sources, and reduces the turnaround times for clinical reports. It automates variant interpretation and report generation, thereby minimizing manual effort and standardizing workflows across various assay types, including comprehensive genomic profiling (CGP) panels, whole-exome sequencing (WES), and transcriptomic data.
Which Leading Companies Dominate The Next-Generation Sequencing Informatics Market Share?
Major companies operating in the next-generation sequencing informatics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Oxford Nanopore Technologies Ltd., GeneDx Holdings Corp., Macrogen Inc., MedGenome Inc., Sophia Genetics SA, DNAnexus Inc., Clear Labs, DNASTAR Inc., Sapio Sciences Inc., Geneious Biomatters Ltd., Genomatix Software GmbH, and CosmosID Inc.
Download The Full Report For Exclusive Market Findings:
Which Regional Markets Are Contributing Most To The Next-Generation Sequencing Informatics Industry Expansion?
North America was the largest region in the next-generation sequencing informatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in next-generation sequencing informatics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Next-Generation Sequencing Informatics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=28282&type=smp
Browse Through More Reports Similar to the Global Next-Generation Sequencing Informatics Market 2025, By The Business Research Company
Next Generation Sequencing Market 2025
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Clinical Oncology Next Generation Sequencing Global Market Report 2025
Clinical Next Generation Sequencing Ngs Data Analysis Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
